The Valdecilla Health Research Institute (IDIVAL) is participating as an associate entity in the European project JADE Health (Joint Action on Dementia and Health System Sustainability), a joint actio...
Read moreIt has been published a study that reveals changes in biomolecular markers of toxicity in babies whose mothers were exposed to organophosphate compounds (pesticides and flame retardants) during pregna...
Read moreAugustine Therapeutics, focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enz...
Read moreThe findings revealed that plasma p-tau biomarkers demonstrated superior accuracy in detecting Alzheimer's compared to other biomarkers, with p-tau217 emerging as the most reliable marker. Notably, p-...
Read moreEste estudio allana el camino para nuevos enfoques médicos centrados en la modulación de la fluidez de las membranas celulares
Read moreThe clinical-stage biotechnology company, Gain Therapeutics, has announced the administration of the first dose to a participant with Parkinson’s disease in its phase 1b clinical trial of GT-02287, ...
Read moreThe review highlights that DNA methylation appears to be a relevant mechanism in stroke. Several studies have identified specific methylation patterns associated with a higher risk of experiencing a c...
Read moreRegenerative medicine has advanced significantly in recent decades, and one of the most promising discoveries in this field is exosomes. These tiny extracellular vesicles are revolutionizing how we un...
Read moreA recent study led by the UAB demonstrates the potential of gene therapy to restore motor capacity in an ultra-rare disease, Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC), even when...
Read moreA study led by IDIBAPS-Hospital Clínic has just detected subtle cognitive deficiencies in people in preclinical stages of the disease, when they are not yet aware of its first symptoms, which could h...
Read moreThe new compound is an inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the regulation of several physiological processes, including inflammation and pain response. In the context o...
Read moreLlevado a cabo por un equipo de investigación del Centro Andaluz de Biología del Desarrollo, el estudio abre nuevas posibilidades para comprender mejor la enfermedad y desarrollar terapias que contr...
Read more